• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION 213, LLC 0113 CHLORAPREP ONE STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION 213, LLC 0113 CHLORAPREP ONE STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL Back to Search Results
Catalog Number 930700
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Sharp Edges (4013)
Patient Problem Abrasion (1689)
Event Date 02/03/2022
Event Type  Injury  
Manufacturer Narrative
(b)(4) initial emdr submission.A follow up emdr will be submitted if additional information becomes available.(b)(4).
 
Event Description
Material# : 930700; batch#: 1305540.It was reported that there were sharps.We would like to file a serious quality compliant on item (b)(4) 10.5ml chlorapreps on lot number 1305540.We filed a psn on this incident.During a procedure yesterday, a patient complained about scratching on the area the chloraprep was applied.The area was bleeding and the end user found glass shards inside the packaging.I¿ve attached a picture.The stock of this lot has been set aside.
 
Manufacturer Narrative
A sample and photo was available for evaluation.Visual examination shows glass particle(s) inside the opened package which verified the reported issue.The foam tip was inspected and it is 100% welded onto the applicator body.The glass might have occurred during the assembly process which inserts a glass ampoule into the applicator body.The equipment has sensors to detect the ampoule presence and scrap non-conforming applicators.A glass ampoule may have been pre-activated during assembly and glass particle(s) may have landed on a nearby applicator.This occurrence is a rare anomaly and this is the first such occurrence on the auto 10.5 ml #2 assembly equipment during the past 12-month review.This failure will be categorized as an isolated event.A production record review was completed for batch/lot 1305540 and no non conformances were identified during the manufacturing of this lot.A training awareness was given to the manufacturing associates and the qa technicians to be aware of such an issue and to clean the equipment upon occurrences when identified.This was also communicated to all manufacturing associates, leads and supervisors.No further action is required.This failure will continue to be tracked and trended.H3 other text : see narrative below.
 
Event Description
It was reported that there were sharps verbatim: we would like to file a serious quality compliant on item 170837a 10.5ml chlorapreps on lot number 1305540.We filed a psn on this incident.During a procedure yesterday, a patient complained about scratching on the area the chloraprep was applied.The area was bleeding and the end user found glass shards inside the packaging.I¿ve attached a picture.The stock of this lot has been set aside.17feb2022 kindly note that one follow up attempt was performed for this case, but no answer was received.If any new information was received, we will notify you.13mar2022:kindly note that one follow-up attempt was performed via phone (on 14-feb-2022 and 17-feb-2022) and e-mail (on 17-feb-2022) for the serious case (b)(4) (bd id: (b)(4)).On 17-feb-2022, reporter¿s reply was received in which the new reporter was mentioned and on 22-feb-2022, the completed fuq form was received (see correspondences attached) and the new case version was opened, i.E.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHLORAPREP ONE STEP
Type of Device
2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL
Manufacturer (Section D)
CAREFUSION 213, LLC 0113
1550 northwestern dr
el paso TX 79912
Manufacturer (Section G)
CAREFUSION, INC
75 n. fairview drive
vernon hills IL 60061
Manufacturer Contact
anna wehrheim
75 n. fairview drive
vernon hills, IL 60061
8015652341
MDR Report Key13534890
MDR Text Key289667278
Report Number3004932373-2022-00049
Device Sequence Number1
Product Code KXG
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/15/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number930700
Device Lot Number1305540
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/28/2022
Was Device Evaluated by Manufacturer? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age79 YR
Patient SexFemale
-
-